Almirall, S.A. to present at J.P. Morgan Healthcare Conference in San Francisco
- Almirall, S.A. will take part in the 37th Annual J.P. Morgan Healthcare Conference in San Francisco.
- A question and answer session will follow after the presentation.
Barcelona 3rd January 2019
Almirall, S.A. (ALM), will present a corporate update at the 37th Annual J.P. Morgan Healthcare Conference on Monday, January 7, 2019 at 10:00 a.m. Pacific Time / 1:00 p.m. Eastern Time at the Westin St. Francis Hotel in San Francisco. The presentation will be followed by a question and answer session that will begin at 10:30 a.m. Pacific Time / 1:30 p.m. Eastern Time.
About Almirall
Almirall is a leading skin-health focused global pharmaceutical company that partners with healthcare professionals, applying Science to provide medical solutions to patients & future generations. Our efforts are focused on fighting against skin health diseases and helping people feel and look their best. We support healthcare professionals in its continuous improvement, bringing our innovative solutions where they are needed. The company, founded 75 years ago and with headquarters in Barcelona, is listed on the Spanish Stock Exchange (ticker: ALM). Almirall has become a key element of value creation to society according to its commitment to major shareholders and its decision to help others, to understand their challenges and to use Science to provide them with solutions for real life. Total revenues in 2017 were 755.8 million euros. More than 1,830 employees are devoted to Science.
For more information, please visit almirall.com linkedin.com/company/almirall
Press release